Famosan

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Famosan

Property Description
Active ingredient Famotidine
Pharmacological class Histamine H2-receptor antagonist (H2-blocker)
Common form Film-coated tablets (Oral)
Primary purpose Inhibition of gastric acid secretion
Origin Synthetic (thiazole derivative)

What Type of Medicine is Famosan (Famotidine)?

Famosan is a medicinal preparation whose active ingredient is the chemical substance Famotidine, which is primarily classified as a dedicated Histamine H2-receptor antagonist, also known as an H2-blocker. This synthetic thiazole derivative is recognized as a potent Gastrointestinal agent due to its specific action within the digestive system. The definitive role of this classification is to establish Famosan as an acid-reducing drug, functioning through the inhibition of gastric acid secretion. Famosan, often available over-the-counter (OTC) in lower strengths, distinguishes itself by offering patients convenient access for managing occasional or night-time heartburn, a typical use scenario.

Famosan Composition and Available Forms

The Famosan preparation is defined as a single-ingredient product, containing only Famotidine as the therapeutically active substance. The drug is most frequently available for systemic delivery in the form of film-coated tablets suitable for oral ingestion, where Famotidine is combined with standard pharmaceutical excipients that form the solid oral base. For immediate or severe clinical circumstances, the medicine is also produced as a sterile powder for injection, allowing for controlled and rapid intravenous (IV) administration when oral intake is not feasible. This dual availability ensures continuous care whether a patient requires fast action in a hospital setting or convenient relief at home.

What is the General Purpose of an H2-Blocker?

The general purpose of Famosan, as an H2-blocker, is to substantially decrease the production of acid in the stomach by engaging in a competitive blockade of the chemical signal that triggers its release. This systemic action leads to the profound inhibition of gastric acid secretion, thereby serving to maintain a less aggressive chemical environment within the upper digestive tract. The primary benefit resulting from this function is the generalized relief of discomfort and burning sensations associated with conditions of excessive stomach acidity. Famotidine is recognized for its clinical importance and utility in foundational health systems globally.

What side effects are possible with Famosan?

Possible side effects and safety information

The official safety profile for Famosan (Famotidine) is structured by governmental regulatory authorities to categorize and communicate documented adverse reactions and specific safety constraints. The majority of reported effects fall into the common and uncommon frequency tiers.

Adverse Reactions by Frequency and System-Organ Class

Adverse reactions are classified based on the rate of occurrence documented in clinical studies and post-marketing surveillance. The most Common effects, occurring in 1% to 10% of patients, include headache, dizziness, constipation, and diarrhea. Effects classified as Uncommon involve other gastrointestinal issues (e.g., nausea, vomiting, abdominal discomfort), skin disorders (e.g., rash, pruritus), and fatigue.

Serious Adverse Reactions

The regulatory profile highlights specific serious adverse reactions that are classified as Very Rare (less than 0.01%). These include severe hypersensitivity reactions (such as anaphylaxis), serious blood disorders (blood dyscrasias like agranulocytosis), hepatitis, and disturbances of the central nervous system (CNS), such as confusion, hallucinations, and seizures.

Population-Specific Safety Considerations

The prescribing information notes that certain patient populations are at an increased documented risk for specific adverse reactions. Patients with renal impairment and older adults are specifically noted to have a higher risk of experiencing CNS adverse reactions due to reduced clearance of the drug. Furthermore, the label stipulates that symptom relief does not exclude the presence of an underlying gastric malignancy, and evaluation must be performed before starting treatment.

Overdose and Emergency Response

Overdose: When to Seek Help

The following information is based strictly on authoritative government regulatory documentation regarding Famotidine (Famosan) overdose and management.

Documented Overdose Presentations

In instances of acute massive oral over-ingestion, the following symptoms have been documented in regulatory sources:

System Affected Manifestations
Cardiac Tachycardia (rapid heartbeat)
Neurological Trembling
Gastrointestinal Vomiting, Abdominal distress
Respiratory Tachypnea (rapid breathing)
General Prostration (extreme exhaustion/collapse)

High-Risk Considerations

Central nervous system (CNS) effects, such as confusion and seizures, are specifically noted in official documentation to be associated with higher Famotidine blood levels. These CNS reactions are more frequently reported in elderly patients and individuals with pre-existing moderate to severe renal impairment.

Required Emergency Action

Immediate medical help must be sought for any suspected overdose. The product information states there is no specific antidote for Famotidine overdose. Management focuses entirely on symptomatic and supportive treatment, including monitoring vital signs and using procedures such as activated charcoal to help eliminate any unabsorbed drug. Contact emergency medical services immediately if the person has collapsed, had a seizure, has trouble breathing, or cannot be awakened.

Therapeutic Uses of Famosan

Main uses of Famosan

Famosan, which contains the active ingredient famotidine, belongs to a class of medications known as histamine-2 (H2) receptor antagonists. It is primarily used to manage conditions related to the overproduction of gastric acid.

Treatment of Gastric and Duodenal Ulcers

Famosan is used for the treatment of active duodenal ulcers and benign gastric ulcers. It aids in the healing process by reducing the amount of acid secreted by the stomach, allowing the lining of the digestive tract to recover. It is also used as maintenance therapy to prevent the recurrence of duodenal ulcers.

Management of Gastroesophageal Reflux Disease (GERD)

This medication is indicated for the treatment of gastroesophageal reflux disease. It helps alleviate symptoms such as heartburn and acid regurgitation by decreasing acid irritation of the esophagus. It is also used to treat erosive esophagitis that has been diagnosed through medical examination.

Hypersecretory Conditions

Famosan is utilized in the management of pathological hypersecretory conditions, where the stomach produces excessive amounts of acid. This includes conditions such as Zollinger-Ellison syndrome and multiple endocrine adenomas.

Benefits of Treatment

Symptom Relief

The primary benefit of Famosan is the relief of discomfort associated with acid-related disorders. By inhibiting the H2 receptors in the gastric parietal cells, the medication effectively lowers both the concentration and volume of gastric acid secretion.

Protection of the Digestive Lining

By maintaining a less acidic environment in the stomach and upper intestine, Famosan supports the healing of existing lesions and helps protect the mucosal lining from further acid-induced damage. This reduction in acidity is beneficial for both the acute healing phase and the long-term prevention of complications associated with chronic acid reflux or ulceration.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Famosan (famotidine) is an H2-receptor antagonist and its use is strictly governed by regulatory eligibility criteria set by agencies such as the FDA and EMA.

Populations That Must Not Use Famosan (Contraindication)

The medicine is contraindicated for any patient with a history of serious hypersensitivity reactions (e.g., anaphylaxis) to famotidine itself or to any other H2-receptor antagonist drug. This exclusion is absolute.

Populations with Restricted or Limited Use

Official labeling defines specific restrictions based on age, weight, and clinical status:

  • Renal Impairment: Patients with moderate or severe kidney impairment (creatinine clearance less than 50 mL/min) must have their dosage reduced. This is necessary to prevent drug accumulation, which increases the risk of Central Nervous System (CNS) adverse reactions and QT prolongation.
  • Pediatric Patients: The use of 20 mg and 40 mg tablets is not recommended for pediatric patients weighing less than 40 kg because the lowest available strength may exceed the recommended weight-based dose. Alternative formulations are advised for these patients. Safety and effectiveness are not established for all indications in all pediatric age groups.
  • Gastric Malignancy: Before starting therapy, particularly for prescription use, the possibility of an underlying gastric malignancy must be evaluated, as symptomatic relief does not rule out the presence of cancer.
  • Pregnancy and Lactation: Famotidine passes into breast milk. A decision must be made to discontinue nursing or discontinue the drug, considering the importance of the medicine to the mother.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Famotidine (Famosan) interacts with other medicines primarily by reducing stomach acid, which is necessary for the proper absorption of many orally taken drugs. This can lead to decreased effectiveness or failure of the co-administered medicine.

Drugs with altered absorption (Decreased Efficacy):

Category Examples (Specific Drugs Listed) Management/Condition
pH-Dependent Oral Medicines Antifungals (e.g., ketoconazole, itraconazole), Tyrosine Kinase Inhibitors (e.g., dasatinib, erlotinib, pazopanib), Certain Antivirals (e.g., atazanavir) Co-administration is often not recommended or requires specific timing (e.g., separate doses by 2 to 10 hours) to maintain the drug’s intended blood level.
Antacids / Sucralfate Antacids, Sucralfate Antacids or Sucralfate may reduce the absorption of Famotidine itself, necessitating staggered administration (e.g., separating doses by 1–2 hours).

Interactions affecting drug concentration:

Famotidine may also affect the concentration of certain medicines in the body through other mechanisms:

  • Tizanidine: The combined use may lead to significantly increased levels of tizanidine, potentially causing excessive drowsiness, low blood pressure, or slow heart rate. Avoid concomitant use if possible.
  • Probenecid: Concurrent use may substantially increase the blood level of Famotidine by reducing its elimination, and is generally avoided.

Condition-Specific Notes

Patients with moderate to severe kidney impairment are at a heightened risk for adverse reactions, including effects on the central nervous system or heart rhythm changes (QT prolongation), due to the slower removal of Famotidine from the body. Dosage adjustment is typically required in this population.

Mechanism of Action

Selective Histamine H2 Receptor Antagonism

Famotidine's action begins by serving as a competitive antagonist that selectively binds to the Histamine H2 receptors on the acid-producing cells of the stomach. By occupying this receptor, Famotidine effectively blocks the signal from the endogenous mediator, histamine, that normally initiates acid production.


Interruption of the Cellular Signaling Cascade

Blocking the H2 receptor directly interrupts the crucial intracellular signaling cascade, preventing the activation of Adenylate Cyclase and subsequently reducing the level of the second messenger, cyclic AMP. This cascade disruption indirectly deactivates the H^+/ K^+ ATPase (Proton Pump), which is the final common pathway for acid release.


Resulting Inhibition of Gastric Acid Secretion

The molecular blockade and subsequent cascade failure result in the physiological consequence of inhibition of both basal and stimulated gastric acid secretion. This systemic effect reduces the volume and acidity of gastric juice, leading to a lower concentration of hydrochloric acid in the upper digestive tract, maintaining this change for an approximate 10-to-12-hour duration.

Dosage and Administration Information

Official Administration Guidelines

Famosan, with the active ingredient Famotidine, is administered through two official routes: the oral route via tablets or suspension, and the intravenous (IV) route for hospitalized patients unable to take oral medication. Usage is structured into defined courses and dose regimens.

Dosing and Administration Schedule

Administration Scope Details
Route and Form Oral (tablets/suspension) or Intravenous (injection solution).
Standard Frequency Once daily (often at bedtime) or Twice daily (in divided doses).
Acute Ulcer Dosing 40 mg once daily or 20 mg twice daily, typically for up to 8 weeks.
IV Dosing 20 mg every 12 hours, administered in a controlled setting.
Hypersecretory Conditions Starting dose is 20 mg every 6 hours, with a maximum authorized dose of 160 mg every 6 hours.

Procedural Requirements

Oral tablets may be taken with or without food. For the IV route, the dose must be administered as an injection over a minimum of two minutes or infused over a 15-to-30-minute period, often requiring dilution. If a dose is missed, it should not be doubled, and the patient should resume the regular schedule at the next scheduled time.

Usage instructions require dose reduction or interval prolongation (e.g., to 36 to 48 hours) for patients with severe renal impairment (creatinine clearance < 10 mL/min or < 30 mL/min). No adjustment is necessary for older adults based on age alone.

Recent Clinical Evidence

Research evidence / Overview of Studies for Famosan


Evidence for Healing Duodenal and Gastric Ulcers

Research includes Randomized Controlled Trials (RCTs) and long-term studies for peptic ulcer disease in adults. These trials evaluated the rate at which ulcers healed and monitored patient-reported experiences of discomfort. Follow-up research tracked recurrence over periods up to 12 months. Current findings apply primarily to the adult populations studied, with data remaining insufficient for preventing recurrence in pediatric groups.


Evidence for Managing GERD and Heartburn

Famosan was studied for its use in managing symptoms of Gastroesophageal Reflux Disease (GERD) and healing associated tissue damage. Evidence is largely drawn from placebo-controlled RCTs that assessed short-term symptom patterns. Research examined outcomes related to patient-reported heartburn frequency, severity, and the speed of measured change. Limited information is available for continuous, long-term maintenance in all GERD patients, as most trials focused on short-term healing or symptomatic relief.


Studies in Specialized Conditions and Patient Groups

Famosan was evaluated for use in rarer conditions, such as Zollinger-Ellison Syndrome, often relying on open-label trials and case series due to low incidence. These studies monitored physiological outcomes related to the control of excessive gastric acid output. Research was also evaluated in specific patient populations, including pediatric patients and older adults. Findings for these groups are generally based on smaller sample sizes, and in older adults, evidence is often extrapolated from primary adult trials.


Gaps and Limitations in Research Data

While Famosan is well-studied, certainty remains low regarding the full range of potential long-term outcomes for continuous use. Evidence quality varies across studies; high-quality RCTs support short-term use, while data for certain specialized groups remains insufficient. Comparative evidence against newer drug classes is also lacking in some scenarios. Research provides context about patterns observed so far but does not offer individual predictions.

Key Studies & References

  1. Famotidine - StatPearls - Comprehensive Clinical Review

Frequently Asked Questions (FAQ)

Common questions about Famosan (FAQ)

Q: What is the main condition or use that Famosan is approved to treat?

Regulatory documents indicate that Famosan is approved to treat and prevent ulcers in the stomach and intestines. It is also used for conditions where the stomach produces too much acid, such as gastroesophageal reflux disease (GERD) and erosive esophagitis.

Q: Is Famosan available as a generic medication, and what is the generic name?

Yes, Famosan is the brand name for the active ingredient famotidine, which is widely available in generic form. For a drug to be approved as a generic, regulatory bodies require it to be bioequivalent, meaning its effects are expected to be the same as the brand-name product.

Q: Is Famosan used to treat the underlying cause of the condition or primarily the symptoms?

Famosan is classified as an H2-blocker and works by reducing the amount of acid produced in the stomach. This mechanism is designed to relieve symptoms like heartburn and support the healing of damaged tissues, such as ulcers.

Q: How long after starting Famosan should I expect to see its intended effects?

The non-prescription guidance indicates the medication may be taken 15 to 60 minutes before consuming items that may cause heartburn. For acute prescribed conditions like ulcers, the treatment duration is typically defined in courses lasting up to 8 to 12 weeks.

Q: Is it normal to experience side effects like headache or mild nausea when first starting Famosan?

Official documents indicate that headache is a commonly reported side effect when taking Famosan. Nausea and vomiting are also listed in regulatory summaries as uncommon adverse reactions.

Q: What is the safety profile of Famosan for use in older adults?

Regulatory documents suggest no overall differences in safety or effectiveness were generally observed between older and younger adults in clinical studies. However, some older individuals may have greater sensitivity to the medication, and a higher risk of Central Nervous System (CNS) side effects has been reported.

Q: Are there any specific foods, drinks, or dietary supplements known to interact with Famosan?

Regulatory documents state that oral tablets may be taken with or without food. Since Famosan reduces stomach acid, it may change how well the body absorbs certain other medications or supplements that require stomach acid to work properly.

Q: Is it safe to consume alcohol while taking Famosan?

The drug label does not list alcohol consumption as a formal contraindication. However, Famosan lists adverse reactions such as dizziness and headache, which may be amplified or worsened by consuming alcohol.

Q: How does Famosan work at a high level, according to official documents?

Famosan is a type of medicine known as a Histamine H2-receptor antagonist, or H2-blocker. This classification means it works by blocking the effect of histamine on the cells that produce acid in the stomach, thereby reducing the acid level.

Q: How is Famosan categorized by regulatory bodies (e.g., drug class)?

Famosan is formally categorized by global regulatory bodies as a Histamine H2-receptor antagonist. This drug class is commonly referred to as an H2-blocker and is defined by its specific action of suppressing stomach acid secretion.

Q: Can Famosan affect my ability to drive or operate machinery?

Official product information indicates that driving or operating machinery should be avoided if adverse reactions such as dizziness or headache are experienced. These effects are listed side effects of Famosan.

Q: Is Famosan considered a short-term or a long-term treatment option?

Famosan is used for the short-term treatment of acute conditions, such as for up to 8 to 12 weeks to heal ulcers. It may also be used for long-term maintenance to reduce the risk of ulcer recurrence, with therapy sometimes lasting up to one year.

Q: Why do some people report feeling more tired or drowsy when starting Famosan?

Regulatory documents list somnolence (drowsiness) as a very rare side effect. Additionally, reports of Central Nervous System (CNS) adverse reactions, which can include lethargy and confusion, are noted in the prescribing information.

Q: Can Famosan be split or crushed, or must it be swallowed whole?

Regulatory consumer instructions indicate that tablets of Famosan are generally intended to be swallowed whole and not chewed. This rule applies unless the specific product you have is explicitly labeled as a chewable tablet.

Q: Where can I find the most complete, official scientific research data on Famosan?

The most complete scientific and clinical data is contained in the full Prescribing Information or Summary of Product Characteristics (SmPC) published by governmental regulatory bodies like the FDA or EMA. These documents summarize all available evidence.

Q: Can Famosan affect my blood pressure?

Official documents indicate that Famosan may indirectly affect blood pressure. For example, a known drug interaction with Tizanidine can cause a drop in blood pressure, and very rarely, cardiac adverse reactions have been reported.

Q: Is Famosan safe for use in pediatric populations, according to official guidelines?

Famosan is approved for use in certain pediatric populations to manage conditions like GERD and ulcers. The determination of the appropriate dose, which is highly dependent on the child's weight and age, is always the role of a healthcare provider.

Q: What is the official storage guidance for Famosan (e.g., room temperature vs. refrigeration)?

The official guidance is to store Famosan in a closed container at room temperature, away from excessive heat, moisture, and light. Official guidance suggests that any oral liquid suspension is typically discarded after 30 days.

Q: Why is Famosan sometimes prescribed along with other medicines for the same condition?

Famosan is sometimes prescribed as part of a combination regimen to manage severe acid-related conditions. This is often necessary for pathological hypersecretory conditions, such as Zollinger-Ellison syndrome, where multiple treatments are needed to control acid output.

Q: Are there different brand names for the same active ingredient as Famosan?

Yes, the active ingredient in Famosan, which is famotidine, is marketed under several different brand names. These include commonly known brands such as Pepcid and Zantac 360.

Q: Do any official studies address the long-term safety profile of Famosan?

Regulatory documents address the long-term safety profile by referencing non-clinical animal studies that examined the effects of the drug over many months. For human use, Famosan is sometimes prescribed for maintenance therapy lasting up to one year.

Q: What are the differences in effectiveness between the brand-name Famosan and the generic version?

For generic famotidine to receive regulatory approval, it must be shown to be bioequivalent to the brand-name Famosan. This regulatory standard means the generic version is expected to work in the same manner and provide the same clinical effect.

How should Famosan be stored and disposed of?

How to Store and Dispose of Famosan (Famotidine)

Official regulatory documents define specific requirements for the storage and disposal of Famosan (Famotidine) products.

Product Form Mandatory Storage Condition Time-Sensitive Requirement
Tablets/Suspension Controlled Room Temperature (15 C–30 C); tightly closed; protect from moisture and light. Reconstituted oral suspension must be discarded after 30 days.
Injection Vials Refrigeration (2 C–8 C) Must be dispensed within 4 hours of initial entry into the vial.

All forms must be protected from freezing and kept out of the reach of children. For disposal, return expired or unused medication to an authorized drug take-back program. If a take-back program is unavailable, follow safe household disposal guidelines (mixing with an undesirable substance like coffee grounds) and do not flush the product down the toilet or drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Famosan found in:

A-Z Index: